Clinical Trials Browser

Phase 1/2 × iodophenyl metomidate × Clear all

NCT00454103 2010-08-18

Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy

Phase 1/2 Completed

Adrenal Gland Neoplasms, Adrenocortical Carcinoma